A Macrocyclic Peptide That Serves As a Cocrystallization Ligand and Inhibits the Function of a MATE Family Transporter

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2013 Sep 4

PMID 23999725

Citations 15

Authors

Christopher J Hipolito

Yoshiki Tanaka

Takayuki Katoh

Osamu Nureki

Hiroaki Suga

Affiliations

Soon will be listed here.

Abstract

The random non-standard peptide integrated discovery (RaPID) system has proven to be a powerful approach to discover de novo natural product-like macrocyclic peptides that inhibit protein functions. We have recently reported three macrocyclic peptides that bind to Pyrococcus furiosus multidrug and toxic compound extrusion (PfMATE) transporter and inhibit the transport function. Moreover, these macrocyclic peptides were successfully employed as cocrystallization ligands of selenomethionine-labeled PfMATE. In this report, we disclose the details of the RaPID selection strategy that led to the identification of these three macrocyclic peptides as well as a fourth macrocyclic peptide, MaD8, which is exclusively discussed in this article. MaD8 was found to bind within the cleft of PfMATE's extracellular side and blocked the path of organic small molecules being extruded. The results of an ethidium bromide efflux assay confirmed the efflux inhibitory activity of MaD8, whose behavior was similar to that of previously reported MaD5.

Citing Articles

Macrocyclic peptides as a new class of targeted protein degraders.

Jing X, Mackay J, Passioura T RSC Chem Biol. 2025; 6(3):326-337.

PMID: 39822773 PMC: 11733494. DOI: 10.1039/d4cb00199k.

Methods for generating and screening libraries of genetically encoded cyclic peptides in drug discovery.

Sohrabi C, Foster A, Tavassoli A Nat Rev Chem. 2023; 4(2):90-101.

PMID: 37128052 DOI: 10.1038/s41570-019-0159-2.

Inhibition of H1 and H5 Influenza A Virus Entry by Diverse Macrocyclic Peptides Targeting the Hemagglutinin Stem Region.

Pascha M, Thijssen V, Egido J, Linthorst M, van Lanen J, van Dongen D ACS Chem Biol. 2022; 17(9):2425-2436.

PMID: 35926224 PMC: 9486808. DOI: 10.1021/acschembio.2c00040.

Directing evolution of novel ligands by mRNA display.

Kamalinia G, Grindel B, Takahashi T, Millward S, Roberts R Chem Soc Rev. 2021; 50(16):9055-9103.

PMID: 34165126 PMC: 8725378. DOI: 10.1039/d1cs00160d.

Expanding the Chemical Diversity of Genetically Encoded Libraries.

Iskandar S, Haberman V, Bowers A ACS Comb Sci. 2020; 22(12):712-733.

PMID: 33167616 PMC: 8284915. DOI: 10.1021/acscombsci.0c00179.

References

Morimoto J, Hayashi Y, Suga H . Discovery of macrocyclic peptides armed with a mechanism-based warhead: isoform-selective inhibition of human deacetylase SIRT2. Angew Chem Int Ed Engl. 2012; 51(14):3423-7. DOI: 10.1002/anie.201108118. View

Tanaka Y, Hipolito C, Maturana A, Ito K, Kuroda T, Higuchi T . Structural basis for the drug extrusion mechanism by a MATE multidrug transporter. Nature. 2013; 496(7444):247-51. DOI: 10.1038/nature12014. View

Cherezov V . Lipidic cubic phase technologies for membrane protein structural studies. Curr Opin Struct Biol. 2011; 21(4):559-66. PMC: 3164297. DOI: 10.1016/j.sbi.2011.06.007. View

Murakami H, Kourouklis D, Suga H . Using a solid-phase ribozyme aminoacylation system to reprogram the genetic code. Chem Biol. 2003; 10(11):1077-84. DOI: 10.1016/j.chembiol.2003.10.010. View

Hayashi Y, Morimoto J, Suga H . In vitro selection of anti-Akt2 thioether-macrocyclic peptides leading to isoform-selective inhibitors. ACS Chem Biol. 2012; 7(3):607-13. DOI: 10.1021/cb200388k. View

Nemoto N, Husimi Y, Yanagawa H . In vitro virus: bonding of mRNA bearing puromycin at the 3'-terminal end to the C-terminal end of its encoded protein on the ribosome in vitro. FEBS Lett. 1997; 414(2):405-8. DOI: 10.1016/s0014-5793(97)01026-0. View

Smith G . Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science. 1985; 228(4705):1315-7. DOI: 10.1126/science.4001944. View

Zhou Y, Kaufman A, Mackinnon R . Chemistry of ion coordination and hydration revealed by a K+ channel-Fab complex at 2.0 A resolution. Nature. 2001; 414(6859):43-8. DOI: 10.1038/35102009. View

Koellhoffer J, Chen G, Sandesara R, Bale S, Saphire E, Chandran K . Two synthetic antibodies that recognize and neutralize distinct proteolytic forms of the ebola virus envelope glycoprotein. Chembiochem. 2012; 13(17):2549-57. PMC: 3684266. DOI: 10.1002/cbic.201200493. View

10.

Iwasaki K, Goto Y, Katoh T, Suga H . Selective thioether macrocyclization of peptides having the N-terminal 2-chloroacetyl group and competing two or three cysteine residues in translation. Org Biomol Chem. 2012; 10(30):5783-6. DOI: 10.1039/c2ob25306b. View

11.

Otsuka M, Matsumoto T, Morimoto R, Arioka S, Omote H, Moriyama Y . A human transporter protein that mediates the final excretion step for toxic organic cations. Proc Natl Acad Sci U S A. 2005; 102(50):17923-8. PMC: 1312386. DOI: 10.1073/pnas.0506483102. View

12.

Paduch M, Koide A, Uysal S, Rizk S, Koide S, Kossiakoff A . Generating conformation-specific synthetic antibodies to trap proteins in selected functional states. Methods. 2013; 60(1):3-14. PMC: 3650108. DOI: 10.1016/j.ymeth.2012.12.010. View

13.

Hipolito C, Suga H . Ribosomal production and in vitro selection of natural product-like peptidomimetics: the FIT and RaPID systems. Curr Opin Chem Biol. 2012; 16(1-2):196-203. DOI: 10.1016/j.cbpa.2012.02.014. View

14.

He X, Szewczyk P, Karyakin A, Evin M, Hong W, Zhang Q . Structure of a cation-bound multidrug and toxic compound extrusion transporter. Nature. 2010; 467(7318):991-4. PMC: 3152480. DOI: 10.1038/nature09408. View

15.

Ohuchi M, Murakami H, Suga H . The flexizyme system: a highly flexible tRNA aminoacylation tool for the translation apparatus. Curr Opin Chem Biol. 2007; 11(5):537-42. DOI: 10.1016/j.cbpa.2007.08.011. View

16.

Ohta A, Yamagishi Y, Suga H . Synthesis of biopolymers using genetic code reprogramming. Curr Opin Chem Biol. 2008; 12(2):159-67. DOI: 10.1016/j.cbpa.2007.12.009. View

17.

Roberts R, Szostak J . RNA-peptide fusions for the in vitro selection of peptides and proteins. Proc Natl Acad Sci U S A. 1997; 94(23):12297-302. PMC: 24913. DOI: 10.1073/pnas.94.23.12297. View

18.

Morimoto J, Hayashi Y, Iwasaki K, Suga H . Flexizymes: their evolutionary history and the origin of catalytic function. Acc Chem Res. 2011; 44(12):1359-68. DOI: 10.1021/ar2000953. View

19.

Murakami H, Ohta A, Ashigai H, Suga H . A highly flexible tRNA acylation method for non-natural polypeptide synthesis. Nat Methods. 2006; 3(5):357-9. DOI: 10.1038/nmeth877. View

20.

Stahl S, Watts N, Rader C, DiMattia M, Mage R, Palmer I . Generation and characterization of a chimeric rabbit/human Fab for co-crystallization of HIV-1 Rev. J Mol Biol. 2010; 397(3):697-708. PMC: 2851401. DOI: 10.1016/j.jmb.2010.01.061. View